| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Executive Officer
2 companies
Winningham Rick E is a Chief Executive Officer at Theravance Biopharma, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 2 sells.
Estimated insider holdings value: $30.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2017 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 5,000 | $150.00 | $750,000.00 | -32.5% | |
| Aug 15, 2016 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 633 | $136.45 | $86,372.85 | -4.0% | |
| Aug 17, 2015 | TBPH Theravance Biopharma, Inc. | Chief Executive Officer | Buy | 80,000 | $11.86 | $948,932.40 | +7.2% |